Michiko Shindo

2.9k total citations
64 papers, 2.4k citations indexed

About

Michiko Shindo is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Michiko Shindo has authored 64 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Hepatology, 53 papers in Epidemiology and 12 papers in Rheumatology. Recurrent topics in Michiko Shindo's work include Hepatitis C virus research (52 papers), Liver Disease Diagnosis and Treatment (39 papers) and Hepatitis B Virus Studies (39 papers). Michiko Shindo is often cited by papers focused on Hepatitis C virus research (52 papers), Liver Disease Diagnosis and Treatment (39 papers) and Hepatitis B Virus Studies (39 papers). Michiko Shindo collaborates with scholars based in Japan, United States and Switzerland. Michiko Shindo's co-authors include Adrian M. Di Bisceglie, Jay H. Hoofnagle, Tse–Ling Fong, Tadao Okuno, S M Feinstone, Michael Fried, Stephen M. Feinstone, Karen Cristiano, J. Wai-Kuo Shih and Nora V. Bergasa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Michiko Shindo

62 papers receiving 2.3k citations

Peers

Countries citing papers authored by Michiko Shindo

Since Specialization

Citations

This map shows the geographic impact of Michiko Shindo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiko Shindo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiko Shindo more than expected).

Fields of papers citing papers by Michiko Shindo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michiko Shindo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiko Shindo. The network helps show where Michiko Shindo may publish in the future.

Co-authorship network of co-authors of Michiko Shindo

This figure shows the co-authorship network connecting the top 25 collaborators of Michiko Shindo. A scholar is included among the top collaborators of Michiko Shindo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michiko Shindo. Michiko Shindo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Malignant Pleural Mesothelioma with Marked Lymphatic Involvement: A Report of Two Autopsy Cases 2017 ·Case Reports in Oncological Medicine ·(unknown), Kazuto Ashizawa, (unknown), Michiko Shindo, (unknown), Toshio Fukuda, Junji Irie, Minoru Fukuda, Masataka Uetani	1
2	Polymorphisms of the Core, NS3, and NS5a Proteins of Hepatitis C Virus Genotype 1b Associate With Development of Hepatocellular Carcinoma 2012 ·Hepatology ·Ahmed El‐Shamy, Michiko Shindo, Ikuo Shoji, Lin Deng, Tadao Okuno, Hak Hotta	29
3	Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A 2007 ·Journal of Autoimmunity ·Toshitaka Akatsuka, (unknown), Takashi Ishikawa, Takafumi Saito, Michiko Shindo, Masayoshi Yamauchi, Kazutaka Kurokohchi, Hitoshi Miyazawa, Hongying Duan, Toshiyuki Matsunaga, Tsugikazu Komoda, Christophe Morisseau, Bruce D. Hammock	15
4	Upregulation of hepcidin by interleukin-1β in human hepatoma cell lines 2005 ·Hepatology Research ·(unknown), Katsuya Ikuta, (unknown), Michiko Shindo, Kei Sato, Yoshihiro Torimoto, (unknown)	34
5	The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B 2004 ·Journal of Gastroenterology ·Michiko Shindo, Kazushige Hamada, Kenichi Nishioji, Akira Muramatsu, (unknown), Tadao Okuno	13
6	Long–Term Follow–Up Study of Sustained Biochemical Responders With Interferon Therapy 2001 ·Hepatology ·Michiko Shindo, Kazushige Hamada, (unknown), Tadao Okuno	54
7	The Clinical Significance of Core Promoter and Precore Mutations During The Natural Course and Interferon Therapy in Patients With Chronic Hepatitis B 1999 ·The American Journal of Gastroenterology ·Michiko Shindo, Kazushige Hamada, (unknown), Yoshihiro Sokawa, Tadao Okuno	22
8	Long-term follow-up of hepatitis G virus/GB virus C replication in liver during and after interferon therapy in patients coinfected with hepatitis C and G viruses 1999 ·Journal of Gastroenterology ·Michiko Shindo, Ken Arai, Tadao Okuno	2
9	The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C 1997 ·Journal of Hepatology ·Michiko Shindo, Ken Arai, Tadao Okuno	20
10	The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy 1996 ·Hepatology ·Michiko Shindo	1
11	Antiviral therapy of hepatitis C — present and future 1993 ·Journal of Hepatology ·Jay H. Hoofnagle, Adrian M. Di Bisceglie, Michiko Shindo	43
12	Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis 1993 ·Digestive Diseases and Sciences ·Michael Fried, (unknown), Michiko Shindo, (unknown), Steven M. Banks, J H Hoofnagle, Adrian M. Di Bisceglie	56
13	Long–Term Follow–Up of Patients With Chronic Hepatitis C Treated With α–Interferon 1992 ·Hepatology ·Michiko Shindo, Adrian M. Di Bisceglie, Jay H. Hoofnagle	167
14	Sensitivity of serological assays to identify blood donors with hepatitis C viraemia 1992 ·The Lancet ·Masahiko Sugitani, Geneviève Inchauspé, A. M. Prince, Michiko Shindo	128
15	A Pilot Study of Ribavirin Therapy for Chronic Hepatitis C 1992 ·Hepatology ·Adrian M. Di Bisceglie, Michiko Shindo, Tse–Ling Fong, Michael Fried, Mark G. Swain, Nora V. Bergasa, Constantine A. Axiotis, Jeanne G. Waggoner, Yoon Park, Jay H. Hoofnagle	236
16	Changes of hepatic and serum HCV RNA level on interferon therapy in patients with chronic hepatitis C. 1991 ·Kanzo ·Masayuki Matsumoto, (unknown), Tadao Okuno, Ken Arai, Michiko Shindo, Makoto Takeda, Takeshi Okanoue, Kei Kashima, Yoshihiro Sokawa	2
17	Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. 1991 ·Journal of Clinical Investigation ·Tse–Ling Fong, Michiko Shindo, S M Feinstone, Jay H. Hoofnagle, Adrian M. Di Bisceglie	180
18	Detection of 2′,5′ oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage 1991 ·Gastroenterologia Japonica ·Tadao Okuno, Michiko Shindo, Ken Arai, Masayuki Matsumoto, Makoto Takeda, Kei Kashima, Yoshihiro Sokawa	2
19	2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during interferon treatment of chronic hepatitis non-A, non-B. 1989 ·Kanzo ·Ken Arai, Michiko Shindo, (unknown), Masayuki Matsumoto, Makoto Takeda, Tatsuro Takino, Yoshihiro Sokawa	2
20	2'-5' oligoadenylate synthetase activity in serum and PBMC of chronic hepatitis B on interferon treatment. 1987 ·Kanzo ·Michiko Shindo, (unknown), Masayuki Matsumoto, Makoto Takeda, (unknown), Tatsuro Takino, Yoshihiro Sokawa, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact